Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 28, 2004New England Journal of MedicineOpen Access

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

RGRoy M. GulickCornell UniversityHRHeather J. RibaudoCancer Research And BiostatisticsCSCecilia M. ShikumaUniversity of Hawaiʻi at Mānoa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gulick et al. (2004) studied this question.

synapsesocial.com/papers/6a1a56be353de69e89b875aehttps://doi.org/10.1056/nejmoa031772
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Combining dependent tests with incomplete repeated measurements1985 · 180 citations
  2. 2Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults1999 · 1,010 citations
  3. 3Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection2000 · 500 citations
  4. 4Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens2003 · 69 citations
  5. 5Mutations in HIV-1 Reverse Transcriptase during Therapy with Abacavir, Lamivudine and Zidovudine in HIV-1-Infected Adults with No Prior Antiretroviral Therapy2002 · 41 citations